Balkanpharma-Dupnitsa AD Merckle GmbH Teva Netherlands B.V. Teva Operations Poland Sp. z o.o.
PolandAll drugs from this manufacturer
-
The medicine is used in adults and children and adolescents (over 10 years of age) for the treatment of relapsing forms of multiple sclerosis (MS), particularly in individuals who have not responded to other treatments or who have a rapidly progressing, severe form of the disease.
Dosage form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.28 mg ATC: L04AE01
-
The medicine is used in adults as well as children and adolescents (over 10 years of age) for the treatment of relapsing forms of multiple sclerosis (MS), particularly in individuals who have not responded to other treatments or who have a rapidly progressing, severe form of the disease.
Dosage form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.56 mg ATC: L04AE01